Flavonoids as Chemosensitizers in Leukemias

dc.contributor.author Huseynova, N.
dc.contributor.author Çetinkaya, M.
dc.contributor.author Baran, Z.
dc.contributor.author Khalilov, R.
dc.contributor.author Mammadova, A.
dc.contributor.author Baran, Y.
dc.date.accessioned 2025-06-25T20:49:22Z
dc.date.available 2025-06-25T20:49:22Z
dc.date.issued 2025
dc.description.abstract Flavonoids, a diverse group of natural compounds abundant in plants, fruits, and seeds, are not only responsible for the vibrant colors, fragrances, and flavors found in nature but also possess significant health benefits. Representing a secondary metabolite, these phytonutrients contribute to overall well-being. They have garnered considerable interest due to their diverse biological roles, encompassing antioxidant, anti-inflammatory, and anticancer properties. Flavonoids exert anticancer properties by interfering with different signaling pathways and molecules. Also, they have been demonstrated to exert chemosensitization features, where flavonoids may enhance the effectiveness of chemotherapy, and hold promise for improving cancer treatment outcomes as they have been discovered to make cancer cells more responsive to treatment. Understanding their influence on the regulation of cellular signaling provides a foundation for exploring their potential in combination with different chemotherapy agents and their possible single use for cancer treatment. Besides, they are believed to present a cost-effective approach to cancer therapeutics with possible implications for reducing the side effects of the current chemotherapy regimens, which can be a great therapeutic strategy for treating cancer types, including leukemia. This chapter explores potential approaches for creating anticancer treatments, focusing on leukemia, through integrating flavonoid nutraceuticals with traditional chemotherapy agents. © 2024. The Author(s), under exclusive license to Springer Nature Switzerland AG. en_US
dc.identifier.doi 10.1007/5584_2024_828
dc.identifier.issn 0065-2598
dc.identifier.scopus 2-s2.0-105003912399
dc.identifier.uri https://doi.org/10.1007/5584_2024_828
dc.identifier.uri https://hdl.handle.net/11147/15620
dc.language.iso en en_US
dc.relation.ispartof Advances in experimental medicine and biology en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Anticancer en_US
dc.subject Chemosensitization en_US
dc.subject Chemotherapeutics en_US
dc.subject Flavonoids en_US
dc.subject Leukemia en_US
dc.title Flavonoids as Chemosensitizers in Leukemias en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.scopusid 59762380700
gdc.author.scopusid 58169672700
gdc.author.scopusid 59537291600
gdc.author.scopusid 57193308858
gdc.author.scopusid 57554611800
gdc.author.scopusid 9636164400
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.department İzmir Institute of Technology en_US
gdc.description.departmenttemp [Huseynova N.] Department of Biophysics and Biochemistry, Baku State University, Baku, Azerbaijan, Department of Natural Sciences, Western Caspian University, Baku, Azerbaijan; [Çetinkaya M.] Department of Molecular Biology and Genetics, Laboratory of Cancer Genetics, İzmir Institute of Technology, İzmir, Turkey; [Baran Z.] Department of Pharmacology, Laboratory of Molecular Pharmacology, Anadolu University, Eskişehir, Turkey; [Khalilov R.] Department of Biophysics and Biochemistry, Baku State University, Baku, Azerbaijan; [Mammadova A.] Department of Botany and Plant Physiology, Baku State University, Baku, Azerbaijan; [Baran Y.] Department of Molecular Biology and Genetics, Laboratory of Cancer Genetics, İzmir Institute of Technology, İzmir, Turkey en_US
gdc.description.endpage 234 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 205 en_US
gdc.description.volume 1479 en_US
gdc.description.wosquality N/A
gdc.identifier.openalex W4404108759
gdc.identifier.pmid 39503945
gdc.index.type Scopus
gdc.index.type PubMed
gdc.oaire.diamondjournal false
gdc.oaire.impulse 1.0
gdc.oaire.influence 2.6385556E-9
gdc.oaire.isgreen false
gdc.oaire.keywords Flavonoids
gdc.oaire.keywords Leukemia
gdc.oaire.keywords Drug Resistance, Neoplasm
gdc.oaire.keywords Humans
gdc.oaire.keywords Animals
gdc.oaire.keywords Antineoplastic Agents
gdc.oaire.keywords Antineoplastic Agents, Phytogenic
gdc.oaire.keywords Signal Transduction
gdc.oaire.popularity 3.0011018E-9
gdc.oaire.publicfunded false
gdc.openalex.collaboration International
gdc.openalex.fwci 6.47494862
gdc.openalex.normalizedpercentile 0.92
gdc.openalex.toppercent TOP 10%
gdc.opencitations.count 0
gdc.plumx.mendeley 6
gdc.plumx.pubmedcites 1
gdc.plumx.scopuscites 2
gdc.scopus.citedcount 2
relation.isAuthorOfPublication.latestForDiscovery 7bb863bb-9384-4a07-9fbb-b9c1ab7634a3
relation.isOrgUnitOfPublication.latestForDiscovery 9af2b05f-28ac-4013-8abe-a4dfe192da5e

Files